Back to search

Article

Upfront fecal microbiota transplantation for the management of immune checkpoint inhibitor mediated diarrhea and colitis

2025-01-13

Abstract excerpt

<title>Abstract</title> <p><bold>Introduction</bold>: Immune checkpoint inhibitors have revolutionized cancer therapy; however, adverse events from an unchecked immune system such as immune checkpoint inhibitor mediated diarrhea and colitis (IMDC) can develop. Fecal microbiota transplantation (FMT) remains an option for patients with refractory colitis, but has not been tested in an upfront setting. <bold>Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d73910b-aadb-51c6-9b94-940361d87770
DOI
10.21203/rs.3.rs-5455153/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Upfront fecal microbiota transplantation for the management of immune checkpoint inhibitor mediated diarrhea and colitisDOI 10.21203/rs.3.rs-5455153/v1
Select a neighboring publication to make it the new centre.